Disease activity following pregnancy-related discontinuation of natalizumab in MS

OBJECTIVE: To investigate disease activity and disability progression following pregnancy-related discontinuation of natalizumab (NTZ) in patients with relapsing-remitting MS. METHODS: A retrospective cohort study of clinical and radiologic data in patients who discontinued NTZ for pregnancy-related...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurol Neuroimmunol Neuroinflamm
Main Authors: Kleerekooper, Iris, van Kempen, Zoé L.E., Leurs, Cyra E., Dekker, Iris, Rispens, Theo, Lissenberg-Witte, Birgit I., van Munster, Caspar E.P., de Jong, Brigit A., van Oosten, Bob W., Uitdehaag, Bernard M.J., Wattjes, Mike P., Killestein, Joep
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5778770/
https://ncbi.nlm.nih.gov/pubmed/29379823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000424
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados